Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation "MSC-FFM"-Outcome Report of 92 Patients.

As was shown, partly contradicting several earlier reports, children and adolescents trended towards better responsiveness to MSCs than adults, but this benefit was modest and did not reach statistical significance ( Figure 3 A).

also in 111,027 other papers